BACKGROUND: The Covid-19 pandemic caused a shutdown of healthcare systems in many countries. We explored the impact on hypertension care in the Excellence Center (EC) network of the European Society of Hypertension. METHODS: We conducted a 17-question electronic survey among ECs. RESULTS: Overall, 52 ECs from 20 European and three non-European countries participated, providing hypertension service for a median of 1500 hypertensive patients per center per year. Eighty-five percent of the ECs reported a shutdown lasting for 9 weeks (range 0-16). The number of patients treated per week decreased by 90%: from a median of 50 (range 10-400) before the pandemic to a median of 5.0 (range 0-150) during the pandemic (P < 0.0001). 60% of patients (range 0-100%) declared limited access to medical consultations. The majority of ECs (57%) could not provide 24-h ambulatory BP monitoring, whereas a median of 63% (range 0-100%) of the patients were regularly performing home BP monitoring. In the majority (75%) of the ECs, hypertension service returned to normal after the first wave of the pandemic. In 66% of the ECs, the physicians received many questions regarding the use of renin-angiotensin system (RAS) blockers. Stopping RAS-blocker therapy (in a few patients) either by patients or physicians was reported in 27 and 36.5% of the ECs. CONCLUSION: Patient care in hypertension ECs was compromised during the Covid-19-related shutdown. These data highlight the necessity to develop new strategies for hypertension care including virtual clinics to maintain services during challenging times.

The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension / Weber, T; Januszewicz, A; Rosei, Ea; Tsioufis, K; Okorie, M; Stergiou, Gs; Volpe, M; Kreutz, R; Abraham, G; Azizi, M; Barna, I; Barroso, Wks; Brguljan, J; Chapman, N; De Backer, T; Dorobantu, M; Eckert, S; Gaciong, Z; Giannattasio, C; Glover, M; Gottsater, A; Grassos, C; Jarai, Z; Aguila, Fj; Kahan, T; Lopez-Sublet, M; Lovic, D; Lurbe, E; Makris, Tk; Mallamaci, F; Manolis, Aj; Marketou, M; Mazza, A; Mediavilla, Jd; Muiesan, Ml; Muxfeldt, Es; Nasr, E; Papadakis, I; Parounak, Z; Obregon, S; Okorie, M; Oliveras, A; Pontremoli, R; Raev, D; Rajkumar, C; Redon, J; Robles, Nr; Rump, Lc; Sarzani, R; Sierra, C; Sirenko, Y; Stojanov, V; Tikkanen, I; Vaclavik, J; Veglio, F; Viigimaa, M; Webb, D; Zebekakis, P; Zweiker, R. - In: JOURNAL OF HYPERTENSION. - ISSN 1473-5598. - 39:1(2021), pp. 190-195. [10.1097/HJH.0000000000002703]

The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension

Volpe, M;Mallamaci, F;
2021

Abstract

BACKGROUND: The Covid-19 pandemic caused a shutdown of healthcare systems in many countries. We explored the impact on hypertension care in the Excellence Center (EC) network of the European Society of Hypertension. METHODS: We conducted a 17-question electronic survey among ECs. RESULTS: Overall, 52 ECs from 20 European and three non-European countries participated, providing hypertension service for a median of 1500 hypertensive patients per center per year. Eighty-five percent of the ECs reported a shutdown lasting for 9 weeks (range 0-16). The number of patients treated per week decreased by 90%: from a median of 50 (range 10-400) before the pandemic to a median of 5.0 (range 0-150) during the pandemic (P < 0.0001). 60% of patients (range 0-100%) declared limited access to medical consultations. The majority of ECs (57%) could not provide 24-h ambulatory BP monitoring, whereas a median of 63% (range 0-100%) of the patients were regularly performing home BP monitoring. In the majority (75%) of the ECs, hypertension service returned to normal after the first wave of the pandemic. In 66% of the ECs, the physicians received many questions regarding the use of renin-angiotensin system (RAS) blockers. Stopping RAS-blocker therapy (in a few patients) either by patients or physicians was reported in 27 and 36.5% of the ECs. CONCLUSION: Patient care in hypertension ECs was compromised during the Covid-19-related shutdown. These data highlight the necessity to develop new strategies for hypertension care including virtual clinics to maintain services during challenging times.
File allegati a questo prodotto
File Dimensione Formato  
Volpe_The corona-virus_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 208.06 kB
Formato Adobe PDF
208.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1542128
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 7
social impact